Trials / Completed
CompletedNCT03864432
An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To determine the pharmacokinetic properties, safety and tolerability of single/multiple oral administration of Gemigliptin and Food effect in healthy Chinese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemigliptin 25mg | Gemigliptin 50mg 1/2T |
| DRUG | Gemigliptin 50mg | Gemigliptin 50mg 1T |
| DRUG | Gemigliptin 100mg | Gemigliptin 50mg 2T |
| DRUG | Gemiglptin 50mg multiple dose | Gemigliptin 50mg 1T \* 10days |
Timeline
- Start date
- 2019-07-02
- Primary completion
- 2019-10-03
- Completion
- 2020-02-28
- First posted
- 2019-03-06
- Last updated
- 2020-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03864432. Inclusion in this directory is not an endorsement.